Nutritional Historical Income Statement

NGS Stock

0.04 0.00 0.00%

Historical analysis of Nutritional Growth income statement accounts such as Interest Expense of 45.9 K can show how well Nutritional Growth Solutions performed in making a profits. Evaluating Nutritional Growth income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Nutritional Growth's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Nutritional Growth latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nutritional Growth is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Nutritional Income Statement Analysis

Nutritional Growth Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Nutritional Growth shareholders. The income statement also shows Nutritional investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Nutritional Growth Income Statement Chart

At this time, Nutritional Growth's Gross Profit is comparatively stable compared to the past year. Research Development is likely to gain to about 355.2 K in 2024, whereas Interest Expense is likely to drop slightly above 45.9 K in 2024.

Interest Expense Total Revenue Other Operating Expenses

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Nutritional Growth generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Nutritional Growth. It is also known as Nutritional Growth overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Nutritional Growth's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Nutritional Growth current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutritional Growth Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	146.6K	88.0K	4.1K	3.9K
Interest Income	47K	113K	249K	132.2K

Depreciation And Amortization Interest Income

Nutritional Growth income statement Correlations

	Tax Provision	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Interest Income	Selling And Marketing Expenses	Net Income From Continuing Ops	Reconciled Depreciation
Tax Provision		-0.45	-0.53	-0.19	0.28	-0.9	-0.9	-0.82	0.61	0.9	0.36	0.9	-0.86	-0.18	0.97	0.95	0.92	0.92	-0.75	-0.63	-0.67	-0.45
Interest Income	-0.45		-0.25	0.16	-0.8	0.47	0.24	0.25	0.05	-0.14	-0.69	-0.14	0.59	-0.59	-0.31	-0.44	-0.16	-0.34	0.46	-0.01	0.71	0.76
Depreciation And Amortization	-0.53	-0.25		-0.13	0.32	0.68	0.79	0.79	-0.87	-0.82	0.5	-0.82	0.57	0.82	-0.71	-0.46	-0.78	-0.73	0.6	0.81	0.23	-0.2
Interest Expense	-0.19	0.16	-0.13		-0.24	-0.12	-0.06	-0.29	0.48	0.03	-0.48	0.03	-0.16	-0.12	-0.15	-0.48	-0.2	0.02	-0.28	-0.24	-0.26	-0.17
Selling General Administrative	0.28	-0.8	0.32	-0.24		-0.29	-0.13	-0.12	-0.16	-0.05	0.56	-0.05	-0.38	0.74	0.16	0.31	0.0	0.2	-0.45	-0.06	-0.7	-0.83
Total Revenue	-0.9	0.47	0.68	-0.12	-0.29		0.96	0.97	-0.82	-0.91	-0.1	-0.91	0.98	0.26	-0.93	-0.77	-0.86	-0.96	0.93	0.79	0.81	0.5
Gross Profit	-0.9	0.24	0.79	-0.06	-0.13	0.96		0.96	-0.87	-0.97	-0.04	-0.97	0.88	0.46	-0.96	-0.79	-0.94	-0.99	0.88	0.89	0.67	0.3
Other Operating Expenses	-0.82	0.25	0.79	-0.29	-0.12	0.97	0.96		-0.94	-0.93	0.1	-0.93	0.92	0.42	-0.88	-0.65	-0.84	-0.95	0.93	0.88	0.74	0.38
Operating Income	0.61	0.05	-0.87	0.48	-0.16	-0.82	-0.87	-0.94		0.86	-0.39	0.86	-0.75	-0.61	0.73	0.42	0.73	0.82	-0.81	-0.89	-0.55	-0.15
Ebit	0.9	-0.14	-0.82	0.03	-0.05	-0.91	-0.97	-0.93	0.86		0.0	1.0	-0.82	-0.56	0.97	0.81	0.97	0.96	-0.77	-0.82	-0.54	-0.17
Research Development	0.36	-0.69	0.5	-0.48	0.56	-0.1	-0.04	0.1	-0.39	0.0		-0.01	-0.14	0.52	0.17	0.45	0.09	0.15	-0.02	0.17	-0.28	-0.41
Ebitda	0.9	-0.14	-0.82	0.03	-0.05	-0.91	-0.97	-0.93	0.86	1.0	-0.01		-0.83	-0.56	0.97	0.81	0.97	0.96	-0.77	-0.82	-0.54	-0.17
Cost Of Revenue	-0.86	0.59	0.57	-0.16	-0.38	0.98	0.88	0.92	-0.75	-0.82	-0.14	-0.83		0.11	-0.86	-0.72	-0.77	-0.89	0.93	0.67	0.87	0.61
Total Operating Expenses	-0.18	-0.59	0.82	-0.12	0.74	0.26	0.46	0.42	-0.61	-0.56	0.52	-0.56	0.11		-0.37	-0.15	-0.53	-0.39	0.12	0.55	-0.28	-0.68
Income Before Tax	0.97	-0.31	-0.71	-0.15	0.16	-0.93	-0.96	-0.88	0.73	0.97	0.17	0.97	-0.86	-0.37		0.92	0.98	0.96	-0.78	-0.75	-0.62	-0.31
Total Other Income Expense Net	0.95	-0.44	-0.46	-0.48	0.31	-0.77	-0.79	-0.65	0.42	0.81	0.45	0.81	-0.72	-0.15	0.92		0.9	0.82	-0.58	-0.5	-0.51	-0.33
Net Income	0.92	-0.16	-0.78	-0.2	0.0	-0.86	-0.94	-0.84	0.73	0.97	0.09	0.97	-0.77	-0.53	0.98	0.9		0.93	-0.68	-0.75	-0.46	-0.12
Income Tax Expense	0.92	-0.34	-0.73	0.02	0.2	-0.96	-0.99	-0.95	0.82	0.96	0.15	0.96	-0.89	-0.39	0.96	0.82	0.93		-0.88	-0.87	-0.71	-0.35
Net Interest Income	-0.75	0.46	0.6	-0.28	-0.45	0.93	0.88	0.93	-0.81	-0.77	-0.02	-0.77	0.93	0.12	-0.78	-0.58	-0.68	-0.88		0.83	0.91	0.63
Selling And Marketing Expenses	-0.63	-0.01	0.81	-0.24	-0.06	0.79	0.89	0.88	-0.89	-0.82	0.17	-0.82	0.67	0.55	-0.75	-0.5	-0.75	-0.87	0.83		0.58	0.16
Net Income From Continuing Ops	-0.67	0.71	0.23	-0.26	-0.7	0.81	0.67	0.74	-0.55	-0.54	-0.28	-0.54	0.87	-0.28	-0.62	-0.51	-0.46	-0.71	0.91	0.58		0.88
Reconciled Depreciation	-0.45	0.76	-0.2	-0.17	-0.83	0.5	0.3	0.38	-0.15	-0.17	-0.41	-0.17	0.61	-0.68	-0.31	-0.33	-0.12	-0.35	0.63	0.16	0.88

Click cells to compare fundamentals

Nutritional Growth Account Relationship Matchups

Nutritional Growth income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Income	85K	140.2K	47K	113K	249K	132.2K
Depreciation And Amortization	13.0K	11.1K	146.6K	88.0K	4.1K	3.9K
Interest Expense	66.2K	1.7M	65K	18K	48.3K	45.9K
Selling General Administrative	2.4M	972.4K	2.1M	1.6M	439.8K	417.8K
Total Revenue	1.7M	1.4M	3.0M	2.9M	3.1M	2.4M
Gross Profit	772.7K	705.5K	1.4M	1.4M	902.6K	1.0M
Other Operating Expenses	4.7M	3.2M	7.8M	7.3M	6.1M	5.9M
Operating Income	(3.0M)	(1.6M)	(4.7M)	(4.2M)	(3.1M)	(3.2M)
Ebit	(2.9M)	(1.6M)	(4.7M)	(4.3M)	(1.9M)	(2.0M)
Research Development	369.8K	183.3K	897K	386K	300.5K	355.2K
Ebitda	(2.8M)	(1.6M)	(4.7M)	(4.2M)	(1.9M)	(2.0M)
Cost Of Revenue	931.0K	728.6K	1.7M	1.5M	2.2M	1.4M
Total Operating Expenses	3.8M	2.4M	6.1M	5.8M	573.2K	544.6K
Income Before Tax	(2.9M)	(3.3M)	(4.8M)	(4.2M)	(3.0M)	(3.1M)
Total Other Income Expense Net	122.3K	(1.7M)	(65K)	(17K)	105.6K	120.4K
Net Income Applicable To Common Shares	(2.0M)	(4.4M)	(4.8M)	(4.2M)	(3.8M)	(4.0M)
Net Income	(2.9M)	(3.3M)	(4.8M)	(4.2M)	(2.0M)	(2.1M)
Income Tax Expense	5.8K	766.89	(146.6K)	(227.5K)	(71.5K)	(75.0K)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nutritional Stock Analysis

When running Nutritional Growth's price analysis, check to measure Nutritional Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutritional Growth is operating at the current time. Most of Nutritional Growth's value examination focuses on studying past and present price action to predict the probability of Nutritional Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutritional Growth's price. Additionally, you may evaluate how the addition of Nutritional Growth to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC